Genix Pharmaceuticals Corporation reported earnings results for the first quarter ended January 31, 2022. For the first quarter, the company reported net loss was CAD 0.338496 million compared to CAD 0.393237 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.05 CAD | +11.11% | +42.86% | +150.00% |
1st Jan change | Capi. | |
---|---|---|
+150.00% | 2.16M | |
+17.10% | 8.44B | |
+14.30% | 6.77B | |
-3.69% | 3.81B | |
-7.34% | 3.71B | |
+1.78% | 1.4B | |
-28.77% | 1.09B | |
+18.84% | 1.03B | |
-11.81% | 901M | |
-18.34% | 785M |
- Stock Market
- Equities
- GENX Stock
- News Genix Pharmaceuticals Corporation
- Genix Pharmaceuticals Corporation Reports Earnings Results for the First Quarter Ended January 31, 2022